Annual Trends in Cleantech Financing & Holiday Party
Thursday, December 2, 2010 from 3:00 PM to 6:30 PM (PST)
Annual Trends in Cleantech financing & Holiday Party
Dec 2 | 3:00 PM - 6:30 PM | Mountain View, CA
Steady capital is a must for all companies. The first step in funding is knowing where to look. Join experts from the investment world at our annual “Trends in Financing Panel & Holiday Celebration” to understand the types of financing that are occurring in your industry today - including topics such as who is getting funding while the world faces complex financial challenges - and what is new and to expect for 2011 Our Panel discussions are candid, interactive and informal. We want you to walk away with the real story behind how things work so you can make it happen yourself.
3:00-3:30: Registration & Networking
3:30-5:00: Panel Discussion
5:45-6:30: Networking Reception & Holiday Party
Our Panel discussions are candid, interactive and informal. We want you to walk away with the real story behind how things work so you can make it happen yourself.
Mark Platshon , Partner, VantagePoint Venture Partners
Brian Goncher , Alternative Energy & Clean Tech Practice Director, Deloitte
Micah Myers , Investment Associate, Claremont Creek Ventures
Nadeem Sheikh, Director for Client Solutions, OPOWER
Kyle McCue, VP New Ventures, Prescience, Intl [moderator]
When & Where
Environmental Business Cluster, powered by Prescience International
Prescience International, which operated the Environmental Business Cluster events, has merged with Johnson & Johson. To view our upcoming events, please visit our new Eventbrite page: http://www.eventbrite.com/org/2487775374?s=11857492.
Dear colleagues and friends,
Having been a patient facing a death sentence, I discovered my passion, my purpose in life was to improve the experience and the outcomes for future patients. I set out to impact the healthcare system by creating new models of innovation so the industry might be as advanced and as revered as the tech industry. By establishing innovation centers such as the San Jose BioCenter, the Environmental Business Cluster and Janssen Labs, and educational programs like the UC Berkeley BioExec Institute, we have helped scientists and entrepreneurs deliver real solutions to real patients and we have fostered a networked community that is creating new lifelines for future patients. I never imagined the impact and reach we could have, and yet, it was only scratching the surface.
I've always felt we needed the partnership of global corporations to leverage their resources, infrastructure and influence to catalyze genuine change in the industry. In collaborating with Johnson & Johnson over the past three years, first on Janssen Labs and most recently with Johnson & Johnson's Innovation Centers, we have found a partner who is just as passionate as we are about patients, their families and the innovators who are dedicated to bringing about transformational healthcare products.
It is with great excitement that I announce Prescience is joining forces with J&J, where we will be dedicated to expanding our impact in global innovation hotspots. As Head of Janssen Labs, I will be reporting directly to Diego Miralles, Global Head, Innovation, Janssen Pharmaceuticals. In this new role, I along with the Prescience team members, will expand J&J's external R&D engine; adding capital efficient infrastructure, high impact services, technical and funding programs and strong networks to provide unparalleled access and engagement with entrepreneurial communities around the globe. We will also continue to support the growth of the Johnson & Johnson Innovation Centers and the development of critical services to support early stage company growth.
We look forward to continue to partner with you as we foster a new era in healthcare solutions where people, ideas, and technologies intersect; where we have an open exchange of ideas and collaboration; where we build custom solutions for the right opportunities; where we create new experiences and outcomes for patients.
Together we can transform patient care and build a healthier future.
Founder & CEO, Prescience International
Head of Janssen Labs